Results 51 to 60 of about 24,947,267 (297)

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent Fc gamma R Pathway [PDF]

open access: yes, 2011
Copyright © 2011, American Society for Microbiology. All Rights Reserved.Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection.
Cheung, Chung y   +40 more
core   +1 more source

Neutralization titers of SARS-CoV-2-nLuc and SARS-CoV-2 variants of concern with sera of macaques prime-boost vaccinated with rVSV-msp-SARS-CoV-2-Gtc.

open access: yes, 2021
Three macaques were prime-immunized intramuscularly with 109 PFU rVSVInd-SARS-CoV-2-msp-SF-Gtc and boost-immunized with 109 PFU of rVSVInd-SARS-CoV-2-msp-SF-Gtc 20 days after the prime-immunization.
Taewoo Kim (1456888)   +30 more
core   +1 more source

SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal [PDF]

open access: yes, 2022
© The Author(s) 2022.BACKGROUND: Genomic surveillance of SARS-CoV-2 in Portugal was rapidly implemented by the National Institute of Health in the early stages of the COVID-19 epidemic, in collaboration with more than 50 laboratories distributed ...
Portuguese network for SARS-CoV-2 genomics (Consortium)
core   +1 more source

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

open access: yesMedComm, 2021
Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in
Xuemei He   +4 more
doaj   +1 more source

SARS-CoV-2 Sequenzdaten aus Deutschland [PDF]

open access: yes, 2021
Für die Planung von Maßnahmen zur Eindämmung von COVID-19 kommt der genauen Kenntnis der Eigenschaften von SARS-CoV-2 eine zentrale Bedeutung zu. Eine besondere Rolle spielen in diesem Zusammenhang Mutationen des Virus.
Robert Koch-Institut
core   +2 more sources

SARS-CoV-2 surveillance in a hospital and control of an outbreak on a geriatric ward using whole genome sequencing

open access: yesInfection Prevention in Practice
Summary: Background: During the SARS-CoV-2 pandemic, dominant viral variants were repeatedly replaced by new variants with altered properties, frequently changing the dynamics of the infection event, as well as the effectiveness of vaccines and ...
Hanno Schmidt   +11 more
doaj   +1 more source

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins

open access: yes, 2020
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is responsible for the current global coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing hundreds of thousands of deaths.
Romain Gasser   +7 more
core   +1 more source

Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches

open access: yes, 2022
Whole-genome sequencing has become an essential tool for real-time genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide.
Ligeon, Véronique   +31 more
core   +1 more source

Monitoring of SARS‐CoV‐2 infection in mustelids

open access: yesEFSA Journal, 2021
American mink and ferret are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but no information is available for other mustelid species.
European Food Safety Authority and European Centre for Disease Prevention and Control   +14 more
doaj   +1 more source

Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. [PDF]

open access: yes, 2006
We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an ...
Donnelly, CA   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy